{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:24:51Z","timestamp":1777353891930,"version":"3.51.4"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T00:00:00Z","timestamp":1448323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0143594","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T21:34:22Z","timestamp":1448400862000},"page":"e0143594","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1"],"prefix":"10.1371","volume":"10","author":[{"given":"Meng-Chuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Feng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Huang","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tz-Chong","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"K Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref2","first-page":"601434","article-title":"Cancer cachexia: mechanisms and clinical implications","author":"CL Donohoe","year":"2011","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/SPC.0000000000000030","article-title":"Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview","volume":"8","author":"N Ebner","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/10408363.2011.586171","article-title":"Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks","volume":"48","author":"SS Wing","year":"2011","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ab.2009.12.026","article-title":"Proteasomal activity in skeletal muscle: a matter of assay design, muscle type, and age","volume":"399","author":"KH Strucksberg","year":"2010","journal-title":"Anal Biochem"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jbspin.2007.04.019","article-title":"Ubiquitin ligases MuRF1 and MAFbx in human skeletal muscle atrophy","volume":"75","author":"L de Palma","year":"2008","journal-title":"Joint Bone Spine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1152\/physiol.00041.2007","article-title":"Signaling in muscle atrophy and hypertrophy","volume":"23","author":"M Sandri","year":"2008","journal-title":"Physiology (Bethesda)"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1096\/fj.03-0610com","article-title":"Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression","volume":"18","author":"SH Lecker","year":"2004","journal-title":"FASEB J"},{"issue":"5547","key":"ref9","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"SC Bodine","year":"2001","journal-title":"Science"},{"issue":"1\u20132","key":"ref10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2013.03.017","article-title":"Signaling pathways mediating the effects of insulin-like growth factor-I in bovine muscle satellite cells","volume":"372","author":"X Ge","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/j.biocel.2005.03.014","article-title":"The pivotal role of cytokines in muscle wasting during cancer","volume":"37","author":"JM Argiles","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1200\/JCO.2001.19.4.1229","article-title":"Gemcitabine and cisplatin for advanced, metastatic bladder cancer","volume":"19","author":"MH Cohen","year":"2001","journal-title":"J Clin Oncol"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"e106489","DOI":"10.1371\/journal.pone.0106489","article-title":"Muscle atrophy in response to cytotoxic chemotherapy is dependent on intact glucocorticoid signaling in skeletal muscle","volume":"9","author":"TP Braun","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"ref14","first-page":"665","article-title":"Chemotherapy: managing side effects and safe handling","volume":"50","author":"V MacDonald","year":"2009","journal-title":"Can Vet J"},{"key":"ref15","first-page":"276186","article-title":"Changes in the mucus barrier during cisplatin-induced intestinal mucositis in rats","author":"H Yamamoto","year":"2013","journal-title":"Biomed Res Int"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.taap.2010.11.003","article-title":"Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems","volume":"250","author":"A Fanzani","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pharmthera.2011.01.010","article-title":"Therapeutic applications of compounds in the Magnolia family","volume":"130","author":"YJ Lee","year":"2011","journal-title":"Pharmacol Ther"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.bcp.2013.02.009","article-title":"Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1alpha\/VEGF signaling pathway in human bladder cancer cells","volume":"85","author":"MC Chen","year":"2013","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.juro.2006.09.074","article-title":"Immunotherapy for orthotopic murine bladder cancer using bacillus Calmette-Guerin recombinant protein Mpt-64","volume":"177","author":"DS Yu","year":"2007","journal-title":"J Urol"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00280-008-0715-9","article-title":"Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution","volume":"63","author":"PM Soares","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"issue":"51","key":"ref21","doi-asserted-by":"crossref","first-page":"40235","DOI":"10.1074\/jbc.M004356200","article-title":"Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation","volume":"275","author":"M Thomas","year":"2000","journal-title":"J Biol Chem"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0006-291X(02)02953-4","article-title":"Inhibition of myostatin in adult mice increases skeletal muscle mass and strength","volume":"300","author":"LA Whittemore","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.biocel.2013.05.019","article-title":"Myostatin\/activin pathway antagonism: molecular basis and therapeutic potential","volume":"45","author":"HQ Han","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1245\/s10434-011-1720-5","article-title":"Changes in myostatin signaling in non-weight-losing cancer patients","volume":"19","author":"Z Aversa","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2362.2008.01970.x","article-title":"Muscle myostatin signalling is enhanced in experimental cancer cachexia","volume":"38","author":"P Costelli","year":"2008","journal-title":"Eur J Clin Invest"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.bbamcr.2011.06.002","article-title":"FoxO transcription factors; Regulation by AKT and 14-3-3 proteins","volume":"1813","author":"G Tzivion","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13539-011-0035-5","article-title":"The role of myostatin in muscle wasting: an overview","volume":"2","author":"Y Elkina","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cmet.2007.11.001","article-title":"FoxO3 controls autophagy in skeletal muscle in vivo","volume":"6","author":"C Mammucari","year":"2007","journal-title":"Cell Metab"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/bjp.2008.153","article-title":"Regulation of muscle mass by growth hormone and IGF-I","volume":"154","author":"CP Velloso","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ncb1101-1009","article-title":"Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways","volume":"3","author":"C Rommel","year":"2001","journal-title":"Nat Cell Biol"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/BJ20070651","article-title":"Effect of branched-chain amino acids on muscle atrophy in cancer cachexia","volume":"407","author":"HL Eley","year":"2007","journal-title":"Biochem J"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/84839","article-title":"Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle","volume":"27","author":"A Musaro","year":"2001","journal-title":"Nat Genet"},{"issue":"4","key":"ref33","first-page":"219","article-title":"Insulin-like growth factor-1 activity is inhibited by interleukin-1 alpha, tumor necrosis factor-alpha, and interleukin-6","volume":"12","author":"DD Lazarus","year":"1993","journal-title":"Lymphokine Cytokine Res"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"X Zhou","year":"2010","journal-title":"Cell"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"TN Stitt","year":"2004","journal-title":"Mol Cell"},{"key":"ref36","first-page":"168407","article-title":"Inflammation based regulation of cancer cachexia","author":"JK Onesti","year":"2014","journal-title":"Biomed Res Int"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","article-title":"Role of interleukin-6 in cachexia: therapeutic implications","volume":"8","author":"AA Narsale","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejca.2009.10.008","article-title":"Expression of NF-kappaB and IkappaB proteins in skeletal muscle of gastric cancer patients","volume":"46","author":"MG Rhoads","year":"2010","journal-title":"Eur J Cancer"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"653","DOI":"10.7150\/ijms.6050","article-title":"Prognostic role of C-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis","volume":"10","author":"Z Zheng","year":"2013","journal-title":"Int J Med Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0143594","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T12:50:16Z","timestamp":1540299016000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0143594"}},"subtitle":[],"editor":[{"given":"Carlos E.","family":"Ambr\u00f3sio","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":39,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0143594","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,24]]}}}